Challenges in Clinical Design of Immunotherapy Trials for Malignant Glioma

INIS

• antigens 16%
• brain 16%
• central nervous system 16%
• chemotherapy 16%
• cytokines 16%
• design 16%
• expansion 16%
• glioblastomas 33%
• gliomas 33%
• harvesting 16%
• immunotherapy 100%
• interactions 16%
• lethals 16%
• molecules 16%
• patients 50%
• radiations 16%
• surgery 16%
• tumor cells 33%
• tumors 50%

Immunology and Microbiology

• Active Immunotherapy 16%
• Adoptive Immunotherapy 33%
• Aptitude 16%
• Cells 16%
• Central Nervous System 16%
• Immune System 33%
• Immunity 50%
• Immunocompetent Cell 33%
• Immunomodulation 33%
• Immunotherapy 50%
• Molecule 16%
• Radiation 16%
• Survival 16%
• Tumor Antigen 16%
• Tumor Cell 33%

Neuroscience

• Brain Tumor 16%
• Chemotherapy 16%
• Glioblastoma Multiforme 33%
• Glioma 33%
• Immunotherapy 50%
• Tumor Antigen 16%